Target intelligence / Profile preview

Fc fragment of IgG receptor and transporter (FcRn)

Target
FcRn
Molecular classification
Receptor, MHC class I-like molecule, Transmembrane glycoprotein, Immunoglobulin superfamily
01

Overview

Murine FcRn, or the neonatal Fc receptor, is a heterodimeric transmembrane protein composed of a heavy chain (encoded by the Fcgrt gene) and a light chain (beta-2-microglobulin). It is structurally related to MHC class I molecules and plays a pivotal role in regulating the homeostasis of immunoglobulin G (IgG) and albumin by protecting them from lysosomal degradation. This protection occurs via a pH-dependent recycling mechanism where FcRn binds ligands in acidic endosomes and releases them back into the bloodstream at neutral pH. In mice, FcRn is also responsible for the transfer of maternal antibodies to neonates across the intestinal epithelium, providing passive immunity. Therapeutically, FcRn is a major target for treating IgG-mediated autoimmune diseases, such as myasthenia gravis and immune thrombocytopenia, where inhibitors are used to accelerate the clearance of pathogenic autoantibodies. Furthermore, the receptor is a key focus in pharmacokinetics, as engineering therapeutic proteins for higher FcRn affinity can significantly extend their serum half-life.

Other names
Neonatal Fc receptorFcgrtIgG receptor FcRn large subunit p51Fc receptor IgG alpha chain transporterIgG Fc fragment receptor transporter alpha chainp51
02

Mechanism of action

Inhibition of the FcRn-IgG interaction to accelerate the catabolism of pathogenic IgG antibodies through a pH-dependent recycling pathway.

03

Biological functions

IgG homeostasisAlbumin homeostasisRecycling and transcytosisAntigen presentationMaternal-fetal antibody transferImmune response
04

Disease associations

Autoimmune diseaseMyasthenia gravisImmune thrombocytopeniaSystemic lupus erythematosusRheumatoid arthritisInfection
05

Safety considerations

Increased risk of infectionHypogammaglobulinemiaHeadachePotential reduction in serum albuminImpaired tumor immunosurveillance
06

Interacting drugs

Efgartigimod

5 more in the full profile.

07

Biomarkers

Serum IgG levelsSerum albumin levelsAutoantibody titersMG-ADL scoreQMG score

Beyond the preview

Go deeper on Fc fragment of IgG receptor and transporter (FcRn).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc fragment of IgG receptor and transporter (FcRn).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call